BreadcrumbHome / Investors / Events and Presentations / Event Details Event Details Jump Links - All Pages OverviewPress ReleasesEvents and PresentationsSEC FilingsCorporate GovernanceStock Information Ocular Therapeutix Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-term Treatment of Dry Eye Disease December 6, 2021 at 8:00 AM EST Additional Resources Investor FAQsInformation Request
Ocular Therapeutix Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-term Treatment of Dry Eye Disease December 6, 2021 at 8:00 AM EST